Related Experiment Video

Updated: May 13, 2026

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy
08:43

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy

Published on: January 24, 2017

Mitochondrial permeability transition pore as a selective target for anti-cancer therapy

Dong H Suh1, Mi-Kyung Kim, Hee S Kim

  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine Seoul, South Korea.

Frontiers in Oncology
|March 14, 2013
PubMed

Insights

Mitochondrial outer membrane permeabilization (MOMP), mediated by the mitochondrial permeability transition pore (MPTP), is crucial for apoptosis. Targeting MPTP offers a promising strategy to overcome cancer treatment resistance and improve tumor selectivity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Mitochondrial outer membrane permeabilization (MOMP) is a key event in apoptosis, often involving the mitochondrial permeability transition pore (MPTP).
  • The MPTP's precise molecular composition remains elusive, yet it is a significant focus for cancer therapy research.
  • MPTP regulation is intrinsically linked to metabolic reprogramming and mitochondrial changes observed in cancer cells.

Purpose of the Study:

  • To review the structure and regulation of the MPTP.
  • To discuss the MPTP's potential in addressing challenges in cancer treatment, specifically tumor selectivity and drug resistance.
  • To summarize the current development status of MPTP-targeting drugs.

Main Methods:

  • Literature review on MPTP structure and regulation.
  • Analysis of MPTP's role in cancer cell apoptosis and metabolism.
  • Survey of pre-clinical and clinical studies on MPTP-targeting agents.

Main Results:

  • The MPTP is implicated in MOMP, a critical step in apoptotic pathways converging on mitochondria.
  • Modulating the MPTP could restore apoptosis in cancer cells, offering a tumor-specific anti-cancer approach.
  • Several MPTP-targeting drugs are currently in pre-clinical and clinical development.

Conclusions:

  • The MPTP represents a promising therapeutic target for cancer treatment.
  • Targeting the MPTP may help overcome resistance and enhance selectivity in cancer therapies.
  • Further research into MPTP structure, regulation, and drug development is warranted.
Keywords:
anti-cancer therapyapoptosiscancermitochondriamitochondrial permeability transition pore

More Related Videos

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria13:42

Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria

Published on: September 7, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...